Our results do not preclude an important role for IL-1α per se, and, indeed, there is recent evidence that cardiac IL-1α is important in cardiac remodeling after MI, as administration of an IL-1α–neutralizing antibody reduced infarct size and preserved LV systolic function in an ischemia/reperfusion model of MI (11). The gene discussed is IL1A; the disease is ischemia.